ES2660642T3 - Formas cristalinas de derivados de dihidropirimidina - Google Patents
Formas cristalinas de derivados de dihidropirimidina Download PDFInfo
- Publication number
- ES2660642T3 ES2660642T3 ES13841041.0T ES13841041T ES2660642T3 ES 2660642 T3 ES2660642 T3 ES 2660642T3 ES 13841041 T ES13841041 T ES 13841041T ES 2660642 T3 ES2660642 T3 ES 2660642T3
- Authority
- ES
- Spain
- Prior art keywords
- compound
- crystalline form
- crystalline
- forms
- crystalline forms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210369019 | 2012-09-27 | ||
| CN201210369019 | 2012-09-27 | ||
| CN201310117076 | 2013-04-04 | ||
| CN201310117076 | 2013-04-04 | ||
| PCT/CN2013/084383 WO2014048355A1 (en) | 2012-09-27 | 2013-09-27 | Crystalline forms of dihydropyrimidine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2660642T3 true ES2660642T3 (es) | 2018-03-23 |
Family
ID=50355923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES13841041.0T Active ES2660642T3 (es) | 2012-09-27 | 2013-09-27 | Formas cristalinas de derivados de dihidropirimidina |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9403814B2 (enExample) |
| EP (1) | EP2900664B1 (enExample) |
| JP (1) | JP6310923B2 (enExample) |
| KR (1) | KR20150060610A (enExample) |
| CN (3) | CN103694234A (enExample) |
| AU (1) | AU2013324779B2 (enExample) |
| BR (1) | BR112015002979B8 (enExample) |
| CA (1) | CA2881260C (enExample) |
| DK (1) | DK2900664T3 (enExample) |
| ES (1) | ES2660642T3 (enExample) |
| HU (1) | HUE037285T2 (enExample) |
| MX (1) | MX362829B (enExample) |
| MY (1) | MY171497A (enExample) |
| PL (1) | PL2900664T3 (enExample) |
| PT (1) | PT2900664T (enExample) |
| RU (1) | RU2646599C2 (enExample) |
| SG (1) | SG11201500145TA (enExample) |
| TW (1) | TWI561520B (enExample) |
| WO (1) | WO2014048355A1 (enExample) |
| ZA (1) | ZA201500290B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6113285B2 (ja) * | 2012-09-10 | 2017-04-12 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｂ型肝炎ウイルス感染症の治療及び予防用の６−アミノ酸ヘテロアリールジヒドロピリミジン |
| WO2017076286A1 (zh) * | 2015-11-04 | 2017-05-11 | 南京明德新药研发股份有限公司 | 二氢吡啶并环化合物的晶型、制备方法和中间体 |
| CN107400125B (zh) * | 2016-05-19 | 2020-02-11 | 广东东阳光药业有限公司 | 二氢嘧啶衍生物的晶型、盐和复合物及其在药物中的应用 |
| CN107722109B (zh) * | 2016-08-11 | 2020-12-18 | 广东东阳光药业有限公司 | 作为丙型肝炎病毒抑制剂的晶型 |
| US9856232B1 (en) * | 2017-06-20 | 2018-01-02 | King Saud University | Dihydropyrimidinone derivatives |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR043880A1 (es) * | 2003-04-22 | 2005-08-17 | Solvay Pharm Gmbh | Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas |
| WO2008154819A1 (fr) | 2007-06-18 | 2008-12-24 | Zhang, Zhongneng | Thiazolyl-dihydropyrimidines à substitution carbéthoxy |
| USRE45004E1 (en) * | 2007-06-18 | 2014-07-08 | Sunshine Lake Pharma Co., Ltd. | Bromo-phenyl substituted thiazolyl dihydropyrimidines |
| CN101328170B (zh) | 2007-06-18 | 2011-09-14 | 张中能 | 一种氟苯基-取代噻唑二氢嘧啶 |
| CN101328168B (zh) | 2007-06-18 | 2011-09-07 | 张中能 | 一种乙氧碳酰基-取代噻唑二氢嘧啶 |
| WO2010069147A1 (zh) * | 2008-12-17 | 2010-06-24 | 张中能 | 二氢嘧啶类化合物、其组合物及其应用 |
| CN101744823B (zh) * | 2008-12-17 | 2013-06-19 | 广东东阳光药业有限公司 | 一种二氢嘧啶类化合物的固体分散体及其药用制剂 |
-
2013
- 2013-09-26 TW TW102134813A patent/TWI561520B/zh active
- 2013-09-26 CN CN201310445326.0A patent/CN103694234A/zh active Pending
- 2013-09-26 CN CN201510364423.6A patent/CN104945394B/zh active Active
- 2013-09-26 CN CN201310446506.0A patent/CN103724339B/zh active Active
- 2013-09-27 HU HUE13841041A patent/HUE037285T2/hu unknown
- 2013-09-27 SG SG11201500145TA patent/SG11201500145TA/en unknown
- 2013-09-27 EP EP13841041.0A patent/EP2900664B1/en active Active
- 2013-09-27 JP JP2015533438A patent/JP6310923B2/ja active Active
- 2013-09-27 ES ES13841041.0T patent/ES2660642T3/es active Active
- 2013-09-27 RU RU2015114085A patent/RU2646599C2/ru active
- 2013-09-27 WO PCT/CN2013/084383 patent/WO2014048355A1/en not_active Ceased
- 2013-09-27 KR KR1020147037155A patent/KR20150060610A/ko not_active Ceased
- 2013-09-27 MX MX2015004115A patent/MX362829B/es active IP Right Grant
- 2013-09-27 CA CA2881260A patent/CA2881260C/en active Active
- 2013-09-27 MY MYPI2015700253A patent/MY171497A/en unknown
- 2013-09-27 US US14/420,666 patent/US9403814B2/en active Active
- 2013-09-27 PT PT138410410T patent/PT2900664T/pt unknown
- 2013-09-27 PL PL13841041T patent/PL2900664T3/pl unknown
- 2013-09-27 BR BR112015002979A patent/BR112015002979B8/pt active IP Right Grant
- 2013-09-27 AU AU2013324779A patent/AU2013324779B2/en active Active
- 2013-09-27 DK DK13841041.0T patent/DK2900664T3/en active
-
2015
- 2015-01-15 ZA ZA2015/00290A patent/ZA201500290B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3246028A1 (en) | KIF18A INHIBITOR | |
| WO2021027911A1 (zh) | 新型螺环类K-Ras G12C抑制剂 | |
| RU2632907C2 (ru) | Дейтерированные диаминопиримидиновые соединения и фармацевтические композиции, содержащие такие соединения | |
| WO2021190467A1 (zh) | 含螺环的喹唑啉化合物 | |
| WO2021078312A1 (zh) | 环烷基类和杂环烷基类抑制剂及其制备方法和应用 | |
| TW202311260A (zh) | 含有亞磺醯亞胺基的atr抑制劑化合物 | |
| ES2660642T3 (es) | Formas cristalinas de derivados de dihidropirimidina | |
| US12378242B2 (en) | Inhibiting CREB binding protein (CBP) | |
| CN114685502A (zh) | 作为kras-g12c抑制剂的螺环类化合物 | |
| KR20230051528A (ko) | 화합물, 조성물 및 방법 | |
| TW202214631A (zh) | 作為Akt激酶抑制劑的化合物 | |
| KR20200145852A (ko) | 항바이러스성 화합물의 고체 형태 | |
| JP2019535644A (ja) | ジヒドロピリミジン化合物並びにその調製方法及び使用 | |
| CN105916506A (zh) | 作为tam家族激酶抑制剂的喹唑啉衍生物 | |
| EA029789B1 (ru) | ПРОИЗВОДНЫЕ ИМИДАЗОПИРИДАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ | |
| WO2021143927A1 (zh) | 作为bcr-abl抑制剂的化合物 | |
| CN116783183A (zh) | 作为vhl抑制剂用于治疗贫血和癌症的1-(2-(4-环丙基-1h-1,2,3-三唑-1-基)乙酰基)-4-羟基-n-(苄基)吡咯烷-2-甲酰胺衍生物 | |
| EP4293022A1 (en) | Dihydropyrimidine compound, preparation method therefor and application thereof | |
| ES3033780T3 (en) | Macrocyclic compounds incorporating piperidine and quinoline or qunaxoline as irak-4 inhibitors for the treatment of inflammatory conditions | |
| AU2020350745B2 (en) | Fused pyridone compound, and preparation method therefor and use thereof | |
| CN107529531A (zh) | 三氮唑－n－苯乙基四氢异喹啉类化合物及其制备方法和应用 | |
| HK40097189A (en) | Compound as akt kinase inhibitor | |
| HK1207081B (en) | Crystalline forms of dihydropyrimidine derivatives | |
| HK40109178A (zh) | 酪氨酸激酶抑制剂 | |
| HK40098215A (en) | Dihydropyrimidine compound, preparation method therefor and application thereof |